UBS Group AG - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTXW and the CUSIP is 92686J114. A total of 5 filers reported holding VIKING THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,000
-75.0%
388
-79.7%
0.00%
Q4 2020$8,0000.0%1,911
+3.5%
0.00%
Q3 2020$8,000
-50.0%
1,847
-34.5%
0.00%
Q2 2020$16,000
+100.0%
2,818
+5.5%
0.00%
Q1 2020$8,000
-57.9%
2,672
-7.7%
0.00%
Q4 2019$19,000
-5.0%
2,894
-21.7%
0.00%
Q3 2019$20,000
-28.6%
3,694
-9.8%
0.00%
Q2 2019$28,000
-17.6%
4,0940.0%0.00%
Q1 2019$34,000
-40.4%
4,094
-56.1%
0.00%
Q4 2018$57,000
+26.7%
9,329
+229.4%
0.00%
Q3 2018$45,000
+9.8%
2,832
-44.3%
0.00%
Q2 2018$41,000
+355.6%
5,080
+62.0%
0.00%
Q1 2018$9,0000.0%3,136
-9.0%
0.00%
Q4 2017$9,0003,448
+1386.2%
0.00%
Q2 2017$02320.0%0.00%
Q1 2017$02320.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Warberg Asset Management LLC 163,536$219,0000.05%
Park West Asset Management LLC 95,600$398,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 9,700$40,0000.00%
UBS Group AG 1,911$8,0000.00%
View complete list of VIKING THERAPEUTICS INC shareholders